Tweet
Medscape
<img alt="" height="1" width="1" />
Rivaroxaban Gets ACS Indication Recommendation From European Regulators
Medscape
LONDON — In a surprise move, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a "positive opinion" regarding extending the indication for rivaroxaban (Xarelto, Bayer Pharma/Janssen ...
Europe and US Diverge On Two New DrugsForbes
Bayer, J&J's Xarelto Wins EU Backing for Expanded UseBusinessweek
Xarelto® recommended for approval in the EUHospital Healthcare Europe
The FINANCIAL
all 10 news articles »
More...